Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Vincenzo Russo
Job title: Chair of Cardiology
Personal History Dr. Russo is based in Naples, Italy, where he holds the Chair of Cardiology at the University of Campania ‘Luigi Vanvitelli’. Academic History Dr. Vincenzo Russo, MD PhD MMSc, graduated in medicine and surgery from Second University of Naples (SUN) in 2005.1 His specialist training in cardiology was undertaken at Monaldi Hospital in Naples, the largest specialist… View more
e-SPACE Heart Failure 2023 – Day One
Author(s): William T Abraham , Stefan Anker , Deepak L Bhatt , et al Start date: Oct 20, 2023

Heart Failure
Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
Author(s): Sebastian Rosch , Karl-Philipp Rommel , Markus Scholz , et al Added: 3 years ago
Heart failure with preserved ejection fraction (HFpEF) is a common disease with rapidly increasing incidence and prevalence due to demographic changes.1 Well-known risk factors, such as metabolic syndrome (arterial hypertension, diabetes, obesity and dyslipidaemia), chronic kidney disease and AF, predispose to the development of HFpEF, especially in older people. Establishing the clinical… View more

Heart Failure
Thumbnail
Author(s): Julio Núñez Added: 2 years ago
In this video interview from ESC's 2021 Heart Failure Congress, Dr Julio Nunez Villota (University of Valencia, Valencia, ES) discusses the findings of the Preserve-HR trial. This was a randomised single-center study that aimed to find the effect of beta-blocker withdrawal in patients with HFpEF and chronotropic incompetence. Questions: 1. Could you briefly remind us of the trial's main aims,… View more

Heart Failure
Aktualisierungen der europäischen Leitlinien zur Herzinsuffizienz: Eine Peer-to-Peer-Diskussion über SGLT-2-Hemmer
Author(s): Gerd Hasenfuß , Michael Böhm , Stefan Anker Added: 2 years ago
In diesem Peer-to-Peer-Video zu den kommenden Herzinsuffizienz-Leitlinien geben uns Prof. Böhm, Prof. Hassenfuß und Prof. Anker eine lokale Interpretation. Zunächst werfen wir einen Blick auf die Richtlinien von 2016 und betrachten dann die Anpassungen der ESC-Herzinsuffizienz-Leitlinien von 2021 und was diese für die Verwendung von SGLT-2-Inhibitoren bei HFrEF bedeuten. Insbesondere betrachten… View more

Standards & Guidelines

Heart Failure
Neurohormonal Modulation in HFpEF
Author(s): Vincenzo Castiglione , Francesco Gentile , Nicolò Ghionzoli , et al Added: 10 months ago

Standards & Guidelines

Heart Failure
e-SPACE Heart Failure 2023 – Day Two
Author(s): William T Abraham , Stefan Anker , Deepak L Bhatt , et al Start date: Oct 21, 2023

Heart Failure
Author(s): Ify R Mordi , Aaron Tee , Chim C Lang Added: 3 years ago
Despite advances in the management of heart failure (HF), a significant burden of mortality and morbidity remains.1 This, combined with the ever-escalating costs of novel drug development, has led to an increased focus on the treatment of comorbidities in order to improve outcomes. As a chronic condition, it is increasingly recognised that HF is actually an iron-deficient state, and is highly… View more

Heart Failure
Predictors for AF-related Cardiomyopathy
Author(s): Erez Marcusohn , Ofer Kobo , Maria Postnikov , et al Added: 2 years ago

Imaging & Diagnostics
Author(s): Ovidiu Chioncel , Sean P Collins , Andrew P Ambrosy , et al Added: 3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches. Pulmonary oedema (PO) is a common manifestation of AHF associated with a… View more

Heart Failure